Regulation of expression of renal organic anion transporters OAT1 and OAT3 in a model of ischemia/reperfusion injury

Cellular Physiology and Biochemistry

Volumn 37, Issue 1, 2015, Pages 1-13

  Preising, Christina ^a   Schneider, Reinhard ^b   Bucher, Michael ^a   Gekle, Michael ^c   Sauvant, Christoph ^a,d  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d eXcorLab GmbH   (Germany)

Author keywords

Cloning of putative human promotor sequence; HEK cells; Ischemic acute kidney injury model; OAT1; OAT3; OK cells; Regulation of expression; Reporter gen assay; Translation; Transport experiments

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; BUTAPROST; FLUORESCEIN; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; TCS 2510; UNCLASSIFIED DRUG; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ORGANIC ANION TRANSPORTER; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROTEIN KINASE INHIBITOR; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ARTICLE; ASSAY; CLONE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; KIDNEY INJURY; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPERFUSION INJURY; REPORTER GENE; CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; GENETIC TRANSCRIPTION; GENETICS; KIDNEY PROXIMAL TUBULE; METABOLISM; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DOWN-REGULATION; EPITHELIAL CELLS; HEK293 CELLS; HUMANS; KIDNEY TUBULES, PROXIMAL; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; PHOSPHODIESTERASE INHIBITORS; PROMOTER REGIONS, GENETIC; PROSTAGLANDIN ANTAGONISTS; PROTEIN KINASE INHIBITORS; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84941179834     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430328     Document Type: Article

References (39)

1. Perri D, Ito S, Rowsell V, Shear NH: The kidney-\-The body's playground for drugs: An overview of renal drug handling with selected clinical correlates. Can J Clin Pharmacol JID-9804162 2003;10:17-23
2. Van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, Meijer DK: Drug uptake systems in liver and kidney. Curr Drug Metab 2003;4:185-211
3. El-Sheikh AA, Masereeuw R, Russel FG: Mechanisms of renal anionic drug transport. Eur J Pharmacol 2008;585:245-255
4. Dantzler WH: Renal organic anion transport: A comparative and cellular perspective. Biochim Biophys Acta 2002;1566:169-181
5. Wright SH, Dantzler WH: Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004;84:987-1049
6. Friis C: Renal transport and metabolism of xenobiotics. Actavetscand 1991;32:S33-43
7. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999;274:13675-13680
8. Sweet DH, Chan LM, Walden R, Yang XP, Miller DS, Pritchard JB: Organic anion transporter 3 (slc22a8) is a dicarboxylate exchanger indirectly coupled to the na+ gradient. Am J Physiol Renal Physiol 2003;284:F763-F769
9. Dantzler WH, Wright SH: The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules. Biochim Biophys Acta 2003;1618:185-193
10. Sekine T, Miyazaki H, Endou H: Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 2006;290:F251-261
11. Corrigan G, Ramaswamy D, Kwon O, Sommer FG, Alfrey EJ, Dafoe DC, Olshen RA, Scandling JD, Myers BD: Pah extraction and estimation of plasma flow in human postischemic acute renal failure. Am J Physiol 1999;277:F312-318
12. Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M: Downregulation of organic anion transporters oat1 and oat3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 2007;292:F1599-1605
13. Matsuzaki T, Watanabe H, Yoshitome K, Morisaki T, Hamada A, Nonoguchi H, Kohda Y, Tomita K, Inui K, Saito H: Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced qacute renal failure. Kidney Int 2007;71:539-547
14. Di Giusto G, Anzai N, Endou H, Torres AM: Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: Role of basolateral plasma membrane transporters and cortical renal blood flow. Pharmacology 2008;81:127-136
15. Sauvant C, Holzinger H, Gekle M: Prostaglandin e2 inhibits its own renal transport by downregulation of organic anion transporters roat1 and roat3. J Am Soc Nephrol 2006;17:46-53
16. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Takamatsu I, Ozawa Y, Saruta T: Role of nitric oxide and prostaglandin e2 in acute renal hypoperfusion. Nephrology (Carlton) 2003;8:65-71
17. Myers SI, Wang L, Liu F, Bartula LL: Suprarenal aortic clamping and reperfusion decreases medullary and cortical blood flow by decreased endogenous renal nitric oxide and pge2 synthesis. J Vasc Surg 2005;42:524-531
18. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Ozawa Y, Saruta T: Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia 10.1152/ajprenal.00012.2001. Am J Physiol Renal Physiol 2002;282:F859-865
19. Schneider R, Meusel M, Renker S, Bauer C, Holzinger H, Roeder M, Wanner C, Gekle M, Sauvant C: Low-dose indomethacin after ischemic acute kidney injury prevents down regulation of oat1/3 and improves renal outcome. Am J Physiol Renal Physiol 2009;297:F1614-1621
20. Sauvant C, Schneider R, Holzinger H, Renker S, Wanner C, Gekle M: Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia. Cell Physiol Biochem 2009;24:567-576
21. Sauvant C, Schneider R, Holzinger H, Renker S, Wanner C, Gekle M: Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model. Am J Nephrol 2010;32:57-65
22. Bischoff A, Bucher M, Gekle M, Sauvant C: Differential effect of cox1 and cox2 inhibitors on renal outcomes following ischemic acute kidney injury. Am J Nephrol 2014;40:1-11
23. Schneider R, Meusel M, Betz B, Held C, Moller-Ehrlich K, Buttner-Herold M, Wanner C, Gekle M, Sauvant C: Oat1/3 restoration protects against renal damage after ischemic aki. Am J Physiol Renal Physiol 2014:ajprenal 00160 02014
24. Sauvant C, Silbernagl S, Gekle M: Exposure to ochratoxin a impairs organic anion transport in proximal-tubule-derived opossum kidney cells. J Pharmacol Exp Ther 1998;287:13-20
25. Ogasawara K, Terada T, Asaka J, Katsura T, Inui K: Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney. Am J Physiol Renal Physiol 2007;292:F1819-1826
26. Ogasawara K, Terada T, Asaka J, Katsura T, Inui K: Human organic anion transporter 3 gene is regulated constitutively and inducibly via a camp-response element. J Pharmacol Exp Ther 2006;319:317-322
27. Wohlfarth V, Drumm K, Mildenberger S, Freudinger R, Gekle M: Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells. Kidney Int Suppl JID-7508622 2003:103-109
28. Sauvant C, Holzinger H, Gekle M: Short-term regulation of basolateral organic anion uptake in proximal tubular ok cells:Prostaglandin e2 acts via receptor mediated activation of pka. J Am Soc Nephrol 2003;14:3017-3026
29. Coskun T, O'Farrell LS, Syed SK, Briere DA, Beavers LS, Dubois SL, Michael MD, Franciskovich JB, Barrett DG, Efanov AM: Activation of prostaglandin e receptor 4 triggers secretion of gut hormone peptides glp-1, glp-2, and pyy. Endocrinology 2013;154:45-53
30. Breyer MD, Breyer RM: Prostaglandin e receptors and the kidney. Am J Physiol Renal Physiol 2000;279:F12-23
31. Breyer MD, Breyer RM: G protein coupled prostanoid receptors and the kidney. Annu Rev Physiol 2001;63:579-605
32. Sauvant C, Schneider R., Betz B., Otremba M., Fischer H., Holzinger H., Wanner C., Galle J., Gekle M: Oat1 and oat3 are down regulated after ischemic acute renal failure in rats. Acta Physiologica 2007;189:104
33. Breljak D, Brzica H, Sweet DH, Anzai N, Sabolic I: Sex-dependent expression of oat3 (slc22a8) and oat1 (slc22a6) proteins in murine kidneys. Am J Physiol Renal Physiol 2013;304:F1114-1126
34. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, Sabolic I: Rat renal cortical oat1 and oat3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 2004;287:F124-138
35. Habu Y, Yano I, Okuda M, Fukatsu A, Inui K-i: Restored expression and activity of organic ion transporters roat1, roat3 and roct2 after hyperuricemia in the rat kidney. Biochem Pharmacol 2005;69:993-999
36. Villar SR, Brandoni A, Anzai N, Endou H, Torres AM: Altered expression of rat renal cortical oat1 and oat3 in response to bilateral ureteral obstruction. Kidney Int 2005;68:2704-2713
37. Shibayama Y, Ushinohama K, Ikeda R, Yoshikawa Y, Motoya T, Takeda Y, Yamada K: Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters oat1, oat2 and oat3 in rats. Cancer Sci 2006;97:1260-1266
38. Kadam RS, Ramamoorthy P, LaFlamme DJ, McKinsey TA, Kompella UB: Hypoxia alters ocular drug transporter expression and activity in rat and calf models: Implications for drug delivery. Mol Pharm 2013;10:2350-2361
39. Bhatnagar V, Xu G, Hamilton BA, Truong DM, Eraly SA, Wu W, Nigam SK: Analyses of 5' regulatory region polymorphisms in human slc22a6 (oat1) and slc22a8 (oat3). J Hum Genet 2006;51:575-580